HOME >> MEDICINE >> NEWS
10 years before malaria vaccine is ready for widespread use

A seminar on malaria in this week's issue of THE LANCET states that it will be at least a decade before a vaccine for the disease will be ready for widespread use and emphasises the need to expand the use of existing control methods.

Brian Greenwood (London School of Hygiene and Tropical Medicine, UK) and colleagues state that prevention and treatment of malaria could be greatly improved with existing methods if increased financial and labour resources were available. Combination therapies based on drugs derived from the plant Artemisia annua (ACTs) have now been adopted by many endemic countries, although cost is likely to be a problem in ensuring their widespread use. ACTs are highly effective, even in areas where there is a high level of resistance to other antimalarial drugs. (See this week's issue Lancet 365; 1467-73, Lancet 365; 1474-1480) Insecticide-treated bed-nets provide a simple but effective means of preventing malaria, especially with the development of longlasting nets in which insecticide is incorporated into net fibres and is not removed during washing.

However, the authors state that new approaches to prevention and treatment are needed including malaria vaccines. One malaria vaccine, RTS, S/AS02 has provided substantial, short-lived protection in volunteers exposed experimentally to bites by infected mosquitoes and in semi-immune adults in The Gambia exposed to natural infection. (See Lancet 2001; 358: 1927-34) In a subsequent trial in Mozambican children, the RTS, S/AS02 vaccine gave 30% protection against the first clinical episode of malaria and 58% protection against severe malaria. (See Lancet 2004; 364: 1411-20) Other promising candidates are undergoing clinical trials.

Professor Greenwood states: "Malaria vaccine research has progressed rapidly over the past few years, helped by the availability more funds and by improved organisation mediated through organisations such as the Malaria Vaccine Initiative. However,
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
21-Apr-2005


Page: 1 2

Related medicine news :

1. Researchers find deadly prescription drug effects 6 years before FDA
2. SCAIS Hildner Lecture traces progress through 30 years of interventional cardiology
3. Speeding fingertip discovery -- 20 years of protein info in 1 place
4. Brain structure changes years before memory loss begins
5. New guideline for screening mammography for women 40 to 49 years of age
6. Worldwide Parkinsons cases will double in next 25 years
7. New research says winning a Nobel Prize adds nearly two years to your lifespan
8. Canadian study shows bilingualism has protective effect in delaying onset of dementia by four years
9. High levels of blindness in southern Sudan following years of war
10. Researchers make progress against lung disease attacking women in childbearing years
11. PhD researcher develops inexpensive, sustainable production method in just 2 years

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: years before malaria vaccine ready for widespread use

(Date:11/28/2014)... 29, 2014 The report “Poxvirus ... on the therapeutic development for Poxvirus Infections, complete ... by drug target, mechanism of action (MoA), route ... latest updates, and featured news and press releases. ... therapeutic development for Poxvirus Infections and special features ...
(Date:11/28/2014)... Recently, PrettyTailor.com has developed and created its ... around the world in celebration of the coming holiday ... launched a special offer on all these outfits. ... pioneer in the garment industry, PrettyTailor.com brings together art ... and small. The business carries quite a few in ...
(Date:11/28/2014)... The holiday season is fast approaching. As a ... collection of fashionable party dresses. What’s more, the company is ... brand new outfits; the special offer is valid until Dec. ... supplier and it has received a lot of requests for ... designed to flatter various body shapes; they are available in ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... Salvage ( http://www.rustysautosalvage.com ), one of the nation's leading ... junk and salvage vehicles to be more competitive and ... customer’s lives during this festive time of year. , ... many car owners across the US also deal with ...
(Date:11/28/2014)... York (PRWEB) November 28, 2014 ... to move forward in New Jersey’s Bergen County ... a consolidated litigation established there is quickly approaching ... updated on November 18th shows 1,293 lawsuits now ... for lawsuits that allege complications resulting from spontaneous ...
Breaking Medicine News(10 mins):Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has ... Drug Application (NDA) for AVP-825. AVP-825 is an ... powder delivered intranasally utilizing a novel Breath Powered ... Response letter, and consistent with the preliminary feedback ...
(Date:11/26/2014)... -- BioScrip ® , Inc. (NASDAQ: BIOS ) announced today ... will present at the Bank of America Merrill Lynch 2014 Leveraged ... , , , Wednesday, December 3, 2014 , , , ... , , Location: , , , Boca Raton Resort and Club, ... BioScrip, Inc. is a leading national provider of ...
(Date:11/26/2014)... 26, 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical ... for infectious diseases, announced today the addition of ... key opinion leader in the areas of pneumonia ... Founder and Chief Executive Officer, ... Opal,s extensive experience investigating bacterial toxins and key ...
Breaking Medicine Technology:Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
Cached News: